Oral Presentations - 1

 Date: 16.01.2021

Hour: 09:00-10:50

Hall: Hall B

Moderator:  Öykü Gönül Geyik, Dilşad Özerkan, Nazlıhan Aztopal

Subject and Speakers: 

Combination of Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Co-Culture and 3D Culture Models of Glioblastoma

Betül Karademir Yılmaz

Therapeutic Potential of CDK4/6 Inhibitor in Triple Negative Breast Cancer Cells

Zeynep Özman

3-Methyl-1-Phenyl-2-Pyrazoline-5-One Bileşiğinin Sıçan Glioma Hücreleri Üzerinde Sitotoksik ve Proapoptotik Etkinliğinin Araştırılması

Canan Vejselova Sezer

Anticancer Effects of Novel Compounds Synthesized by The Reaction of Various Substituents Containing Chalcones with Barbituric Acid Derivatives

İmge Kunter

Small Molecule Inhibitor of Nicotinamide N-Methyltransferase Shows Anti-Proliferative Activity in Hela Cells

Tuğçe Duran

Investigation of Anti-Proliferative and Apoptotic Effects of Newly Synthesis of Pyrazole Derivative (BPM) on Human Breast Cancer Cell Line

Ebru Haciosmanoglu

Co-Culture of Laryngeal Cancer Cells and Endothelial Cells Results in The Changes of Phenotypic and Molecular Properties of Tumour Microenvironment

Zeynep Betül SARI

Drug Repurposing By Synergistic Combination Therapy Of Valproic Acid and Spironolactone Induces Apoptosis In Lung Cancer

Mehmet Emin Köse

Cyclophosphamide Enhanced the Effect of Altiratinib, a c-MET Inhibitor, Through Induction of Apoptosis in Glioblastoma Cells

Sadaf Mahfooz

The Effect of Royal Jelly on Caspase-3, Caspase-6, Bax, Bcl-2 and VEGF Protein Signaling Pathways Against Fluoride-Induced Kidney Damage in Rats

Seda Beyaz